With its purely refractive design, the TECNIS PureSee IOL ensures surgeons’ ease of use in providing high tolerance to ...
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
1d
Hosted on MSNSeven innovative student design projects that enhance healthcareDezeen School Shows: we've rounded up seven student projects featured in Dezeen School Shows that utilise modern technology ...
Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...
Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that ...
Contributor content. As a health care IT specialist, Vedamurthy Yogeshappa uses Artificial Intelligence (AI) to streamline ...
Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.
For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Dr. Diamond’s Metacine adds a third and final product to the InstaFacial Collection, making its results even more impressive.
(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results